Compare ETG & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ETG | ATRC |
|---|---|---|
| Founded | N/A | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.7B |
| IPO Year | 2003 | 2005 |
| Metric | ETG | ATRC |
|---|---|---|
| Price | $22.90 | $39.80 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $51.17 |
| AVG Volume (30 Days) | 72.6K | ★ 965.1K |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 74.74 |
| EPS | N/A | ★ 0.18 |
| Revenue | N/A | ★ $201,630,000.00 |
| Revenue This Year | N/A | $15.27 |
| Revenue Next Year | N/A | $12.21 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 15.40 |
| 52 Week Low | $19.34 | $25.36 |
| 52 Week High | $23.76 | $43.18 |
| Indicator | ETG | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 45.67 | 75.39 |
| Support Level | $22.76 | $39.40 |
| Resistance Level | $23.44 | $42.89 |
| Average True Range (ATR) | 0.26 | 1.47 |
| MACD | -0.07 | 0.28 |
| Stochastic Oscillator | 23.31 | 98.56 |
Eaton Vance Tax Advgd Gbl Div Inc Fd is a diversified, closed-end management investment company. Its investment objective is to provide a high level of after-tax total return consisting of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. Its portfolio of investments consists of aerospace and defense, capital markets, diversified telecommunication services, electrical equipment, biotechnology, banks, and other areas.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.